fda warning glp-1 compounding september 2025 Congress Introduces SAFE Drugs Act of 2025, Expanding Oversight of Compounded Drugs and Telehealth Providers FDA Issues Warnings Against Illegal

GLP-1 medications are typically prescribed for individuals who have a body mass index (BMI) of 30 or higher, or for those with a BMI of 27 or higher who also have at least one weight-related health condition, such as type 2 diabetes or high blood pressure

Their primary mode of action involves binding to ergosterol, a key sterol component of fungal cell membranes, leading to the formation of pores that disrupt membrane integrity and cause leakage of intracellular ions such as Na + , K + , H + , and Cl - , ultimately inhibiting fungal growth (Gray et al., 2012

Le Foll, C

Understanding whats driving it makes it much easier to manage, and for most people, it responds well to targeted adjustments without needing to stop the medication

Flexibility and Mobility Work Limited hip flexibility increases adductor strain risk by forcing the muscles to work through inadequate range of motion

Molecular updates on berberine in liver diseases: bench to bedside